New pill may ease severe cancer pain
NCT ID NCT06533657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental oral drug called Trichomylin® in 11 adults with advanced cancer who had moderate to severe pain despite taking strong opioids. The goal was to see if the drug is safe and can provide additional pain relief. Participants took the drug twice daily, and researchers measured changes in pain scores and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CancerCare Manitoba
Winnipeg, Manitoba, Canada
-
Centre hospitalier de l'Université de Montréal
Montreal, Quebec, H2X 0C1, Canada
-
The Research Institute of the McGill University Health Centre
Montreal, Quebec, H3H 2R9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden risk: could opioid misuse be overlooked in cancer care?
- Could common painkillers boost opioid effectiveness for cancer patients?
- New Low-Dose pain patch aims to ease cancer suffering
- Radiosurgery zaps cancer pain when opioids fail
- Can video calls replace clinic visits for cancer pain?
- Massage therapy may ease painful sex after gynecological cancer